Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer. The new guidelines, developed for the British Society of Gastroenterology by academics at the Universities of Newcastle, Oxford, Central Lancashire and others, have been published in the UK